Human trials of cancer drug PAC-1 continue with new investment
Chemistry professor Paul Hergenrother (right) and veterinary clinical medicine professor Timothy Fan tested an anti-cancer compound in pet dogs now being used in human clinical trials.
Shape of tumor may affect whether cells can metastasize
Illinois researchers found the shape of a tumor may play a role in how cancer cells become primed to spread. led by materials science and engineering professor Kristopher Kilian (left).
Sequence features accurately predict genome-wide MeCP2 binding in vivo
Illinois researchers along with UC Davis are combining in vivo and computational techniques to predict a genome-wide binding pattern of a key protein involved in brain disorders.
Tumor Development Studies Across Species Can Lead to New Cancer Drugs
Associate Professor of Oncology Timothy Fan writes how studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.
Cancer and Companion Animals Focus of New IGB Theme
New theme at the IGB, Anticancer Discovery from Pets to People (ACPP), to focus on developing anticancer drugs through the use of preclinical animal models - especially dogs and cats.
ACPP Theme Leader Speaks to Illinois Senator Dick Durbin
Professor of Chemistry and ACPP Theme Leader Paul Hergenrother details the impact of NIH funding to Illinois Senator Dick Durbin, and describes the new Pets to People IGB Theme. Professor Hergenrother’s remarks begin at the ~22 minute mark.
Cancer drug first tested in pet dogs begins human trials
University of Illinois chemistry professor Paul Hergenrother and veterinary clinical medicine professor Timothy Fan tested an anti-cancer compound in pet dogs that will be used in human clinical trials.
